HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents].

Abstract
The paper presents the results of studying the spectrum of influenza A and B viruses to rimantadine, arbidol, and oseltamivir and describes the methods used for these purposes for epidemiological surveillance. Different sensitivities to rimantadine were found among influenza A viruses. During the 2007-2008 season, the vast majority of influenza A(H3N2) virus strains were resistant to rimantadine (77%) while all influenza A(H1N1) virus strains preserved their resistance to this drug. The fact that the epidemic influenza A(H1N1) virus strains that carry the mutation responsible for resistance to the neuraminidase inhibitor oseltamivir (Tamiflu) circulated in the Russian Federation was first established. At the same time all the study influenza A(H1N1) virus strains preserved their susceptibility to rimantadine. The sensitivity of the epidemic strains to arbidol has been confirmed.
AuthorsE I Burtseva, E S Shevchenko, N V Beliakova, T A Oskerko, L V Kolobukhina, L N Merkulova, R V Vartanian, A G Prilipov, M Rotanov, A L Zaplatnikov
JournalVoprosy virusologii (Vopr Virusol) 2009 Sep-Oct Vol. 54 Issue 5 Pg. 24-8 ISSN: 0507-4088 [Print] Russia (Federation)
PMID19882899 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Indoles
  • Rimantadine
  • Oseltamivir
  • umifenovir
Topics
  • Antiviral Agents (pharmacology)
  • Disease Outbreaks
  • Drug Resistance, Viral (genetics)
  • Environmental Monitoring
  • Epidemiological Monitoring
  • Humans
  • Indoles (pharmacology)
  • Influenza A Virus, H1N1 Subtype (drug effects, genetics, isolation & purification)
  • Influenza A Virus, H3N2 Subtype (drug effects, genetics, isolation & purification)
  • Influenza, Human (epidemiology, virology)
  • Microbial Sensitivity Tests
  • Mutation
  • Oseltamivir (pharmacology)
  • Rimantadine (pharmacology)
  • Russia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: